Latest News & Features
Refine Search
Americas
Pharmaceutical company Eli Lilly has said its profits fell by more than 50% in the most recent quarter, citing patent expirations and generic competition as contributing factors. 23 October 2014
Big Pharma
Pharmaceutical company Roche has announced it will be building a new multi-billion research and development centre. 22 October 2014
Americas
The US Court of Appeals for the Federal Circuit has limited a judge’s power to enforce local rules in a patent dispute involving pharmaceutical company Pfizer and an anti-cancer treatment company. 21 October 2014
Big Pharma
Pharmaceutical and biologics company AstraZeneca and the University of Cambridge have teamed up as part of a programme aimed at increasing life science-related research and teaching. 20 October 2014
Americas
The US Supreme Court was split yesterday (October 15) after hearing arguments in a high-profile case that will determine whether generic drug companies are free to market a cheaper version of Teva’s blockbuster multiple sclerosis drug. 16 October 2014
Americas
Biotechnology company Capricor Therapeutics has agreed to acquire patents from medical equipment maker Medtronic as part of plans to develop a programme to treat heart failure. 15 October 2014
Americas
The highest court in the US will hear a dispute today (October 15) between pharmaceutical company Teva and generic rivals that are looking to market versions of its multiple sclerosis drug Copaxone (glatiramer acetate). 15 October 2014
Big Pharma
UK-based law firm Carpmaels & Ransford LLP has continued to expand its IP group with the appointment of a life sciences litigator to its London office. 15 October 2014
Americas
The US government has launched a new investigation into India’s IP regime just weeks after a meeting between the country’s new prime minister and US President Barack Obama. 14 October 2014
Asia
US pharmaceutical company Pfizer has been granted a patent for an anti-fungal drug in India after overcoming local opposition. 13 October 2014